Clinical Trials Update: Aug. 2, 2005
Progressive Multifocal Leukoencephalopathy (PML) High Cholesterol (Hyperlipidemia) Diabetic Neuropathy
(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
Progressive Multifocal Leukoencephalopathy (PML)
The Division of Infectious Disease and the Department of Neurology at the Massachusetts General Hospital and the Brigham and Women's Hospital are conducting an observational research study of patients with PML in order to devise new ways to improve a person's immune response. Participants must be adults between the ages of 18-64. Research site located in Boston, Mass.
High Cholesterol (Hyperlipidemia)
To qualify for this cholesterol study, you must be at least 21 years if age and in general good health, have a history of high cholesterol, whether on medicine or not, and be willing to do your best to adhere to a low-fat diet (as recommended by the American Heart Association) for length of the study. Qualified participants will receive the following at no charge: study related physical exams, lab work, investigational study medication, ECG and diet assessments. Research site located in Mount Pleasant, SC.
This is a randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and the safety of three doses of TAK-128, an investigational medication, in people with mild-to-moderate diabetic peripheral neuropathy. This phase II study will involve 11 visits over seven months. Compensation of up to $850.00 will be given upon completion. Must be ages 18-70, be diabetic type 1 or 2, been participating in stable diabetic therapy for at least three months, and been on stable diabetic neuropathy medication for at least six weeks prior to study entry. Research site located in West Palm Beach, Fla.
Copyright 2005 CenterWatch. All rights reserved.